Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries
Ed.: Harpum, Pete
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries
Ed.: Harpum, Pete
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book gives an expert view of how the project management approach can be taken forward by the pharmaceutical industry over the next decade. The book integrates portfolio, program, and project management processes as fundamentals for effective and efficient drug product development. This discussion has already begun at conferences, including the Drug Information Association conference on project management held in Philadelphia in February 2005, for which book editor Harpum was a co-chairperson.
Andere Kunden interessierten sich auch für
- Pharmaceutical Manufacturing Handbook277,99 €
- Pharmaceutical Manufacturing Handbook281,99 €
- Pharmaceutical Manufacturing Handbook, 2 Volume Set412,99 €
- Derek WalkerChemical Process Development170,99 €
- Preclinical Development Handbook277,99 €
- Preclinical Development Handbook274,99 €
- Preclinical Development Handbook, 2 Volume Set417,99 €
-
-
-
This book gives an expert view of how the project management approach can be taken forward by the pharmaceutical industry over the next decade. The book integrates portfolio, program, and project management processes as fundamentals for effective and efficient drug product development. This discussion has already begun at conferences, including the Drug Information Association conference on project management held in Philadelphia in February 2005, for which book editor Harpum was a co-chairperson.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons
- Artikelnr. des Verlages: 14504966000
- 1. Auflage
- Seitenzahl: 352
- Erscheinungstermin: 5. April 2010
- Englisch
- Abmessung: 244mm x 162mm x 29mm
- Gewicht: 625g
- ISBN-13: 9780470049662
- ISBN-10: 0470049669
- Artikelnr.: 28174946
- Verlag: Wiley & Sons
- Artikelnr. des Verlages: 14504966000
- 1. Auflage
- Seitenzahl: 352
- Erscheinungstermin: 5. April 2010
- Englisch
- Abmessung: 244mm x 162mm x 29mm
- Gewicht: 625g
- ISBN-13: 9780470049662
- ISBN-10: 0470049669
- Artikelnr.: 28174946
PETE HARPUM is a Director of Harpum Consulting and has been consulting on Portfolio, Program, and Project Management (P3M) for some ten years. He chairs and contributes to many conferences and symposiums on P3M. Mr. Harpum's other activities include postgraduate lecturing and research on P 3M for three world-class universities, and supporting the Association for Project Management, Project Management Institute, and the Drug Information Association in various ways.
List of Contributors. Acknowledgements. Introduction. SECTION I. The Life
Science Industry Context for Portfolio, Program, and Project Management.
Introduction. 1 A Review of Project Management in Life Science Industry
Sectors (Thomas R. Dunson). 2 The Impact of Organizational Size on Drug
Project Management (Eric Morfin). 3 Drug Development in Biotech and How We
Can Do It Better (Susan Linna). SECTION II. The Portfolio, Program, and
Project Management Approaches and Processes. Introduction. 4 An Overview of
the Organization and Processes of Portfolio, Program and Project Management
(Pete Harpum). 5 Portfolio Management in the Pharmaceutical Industry:
Balancing Corporate Need with the Reality of Delivering Products to the
Market (John Bennett). 6 Program Management in Drug Development (Pauline
Stewart-Long). 7 Project Control (Martin Powell). 8 Managing Uncertainty in
Drug Projects (Pete Harpum and Thomas R. Dunson). 9 Managing Drug Safety
Risk (Thomas R. Dunson and Eric Morfin). 10 Developing Program Strategy
(Pete Harpum). 11 Project Value Management: Ensuring the Development of
Added Value Drug Products (Trevor Brown and Stephen Allport). SECTION III.
Integrating the Processes. Introduction. 12 Integrated Business Process to
Support Cross-Functional Drug Development (Martin D. Hynes III). 13
Integrated Drug Development From Cradle to Grave and From Lab to Market
(Stephen Allport and Terry Cook-Davies). 14 The Development of P3M
Capability in Drug Development Organizations (John Arrowsmith, Patrick
Grogan and Bob Moore). 15 Implementing Portfolio, Program, and Project
Management Best Practices in Drug Development Organizations (Pete Harpum,
Ashley Jamieson and Inge Fisher). Bibliography.
Science Industry Context for Portfolio, Program, and Project Management.
Introduction. 1 A Review of Project Management in Life Science Industry
Sectors (Thomas R. Dunson). 2 The Impact of Organizational Size on Drug
Project Management (Eric Morfin). 3 Drug Development in Biotech and How We
Can Do It Better (Susan Linna). SECTION II. The Portfolio, Program, and
Project Management Approaches and Processes. Introduction. 4 An Overview of
the Organization and Processes of Portfolio, Program and Project Management
(Pete Harpum). 5 Portfolio Management in the Pharmaceutical Industry:
Balancing Corporate Need with the Reality of Delivering Products to the
Market (John Bennett). 6 Program Management in Drug Development (Pauline
Stewart-Long). 7 Project Control (Martin Powell). 8 Managing Uncertainty in
Drug Projects (Pete Harpum and Thomas R. Dunson). 9 Managing Drug Safety
Risk (Thomas R. Dunson and Eric Morfin). 10 Developing Program Strategy
(Pete Harpum). 11 Project Value Management: Ensuring the Development of
Added Value Drug Products (Trevor Brown and Stephen Allport). SECTION III.
Integrating the Processes. Introduction. 12 Integrated Business Process to
Support Cross-Functional Drug Development (Martin D. Hynes III). 13
Integrated Drug Development From Cradle to Grave and From Lab to Market
(Stephen Allport and Terry Cook-Davies). 14 The Development of P3M
Capability in Drug Development Organizations (John Arrowsmith, Patrick
Grogan and Bob Moore). 15 Implementing Portfolio, Program, and Project
Management Best Practices in Drug Development Organizations (Pete Harpum,
Ashley Jamieson and Inge Fisher). Bibliography.
List of Contributors. Acknowledgements. Introduction. SECTION I. The Life
Science Industry Context for Portfolio, Program, and Project Management.
Introduction. 1 A Review of Project Management in Life Science Industry
Sectors (Thomas R. Dunson). 2 The Impact of Organizational Size on Drug
Project Management (Eric Morfin). 3 Drug Development in Biotech and How We
Can Do It Better (Susan Linna). SECTION II. The Portfolio, Program, and
Project Management Approaches and Processes. Introduction. 4 An Overview of
the Organization and Processes of Portfolio, Program and Project Management
(Pete Harpum). 5 Portfolio Management in the Pharmaceutical Industry:
Balancing Corporate Need with the Reality of Delivering Products to the
Market (John Bennett). 6 Program Management in Drug Development (Pauline
Stewart-Long). 7 Project Control (Martin Powell). 8 Managing Uncertainty in
Drug Projects (Pete Harpum and Thomas R. Dunson). 9 Managing Drug Safety
Risk (Thomas R. Dunson and Eric Morfin). 10 Developing Program Strategy
(Pete Harpum). 11 Project Value Management: Ensuring the Development of
Added Value Drug Products (Trevor Brown and Stephen Allport). SECTION III.
Integrating the Processes. Introduction. 12 Integrated Business Process to
Support Cross-Functional Drug Development (Martin D. Hynes III). 13
Integrated Drug Development From Cradle to Grave and From Lab to Market
(Stephen Allport and Terry Cook-Davies). 14 The Development of P3M
Capability in Drug Development Organizations (John Arrowsmith, Patrick
Grogan and Bob Moore). 15 Implementing Portfolio, Program, and Project
Management Best Practices in Drug Development Organizations (Pete Harpum,
Ashley Jamieson and Inge Fisher). Bibliography.
Science Industry Context for Portfolio, Program, and Project Management.
Introduction. 1 A Review of Project Management in Life Science Industry
Sectors (Thomas R. Dunson). 2 The Impact of Organizational Size on Drug
Project Management (Eric Morfin). 3 Drug Development in Biotech and How We
Can Do It Better (Susan Linna). SECTION II. The Portfolio, Program, and
Project Management Approaches and Processes. Introduction. 4 An Overview of
the Organization and Processes of Portfolio, Program and Project Management
(Pete Harpum). 5 Portfolio Management in the Pharmaceutical Industry:
Balancing Corporate Need with the Reality of Delivering Products to the
Market (John Bennett). 6 Program Management in Drug Development (Pauline
Stewart-Long). 7 Project Control (Martin Powell). 8 Managing Uncertainty in
Drug Projects (Pete Harpum and Thomas R. Dunson). 9 Managing Drug Safety
Risk (Thomas R. Dunson and Eric Morfin). 10 Developing Program Strategy
(Pete Harpum). 11 Project Value Management: Ensuring the Development of
Added Value Drug Products (Trevor Brown and Stephen Allport). SECTION III.
Integrating the Processes. Introduction. 12 Integrated Business Process to
Support Cross-Functional Drug Development (Martin D. Hynes III). 13
Integrated Drug Development From Cradle to Grave and From Lab to Market
(Stephen Allport and Terry Cook-Davies). 14 The Development of P3M
Capability in Drug Development Organizations (John Arrowsmith, Patrick
Grogan and Bob Moore). 15 Implementing Portfolio, Program, and Project
Management Best Practices in Drug Development Organizations (Pete Harpum,
Ashley Jamieson and Inge Fisher). Bibliography.